The 5 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 23.00, with a high estimate of 31.00 and a low estimate of 10.00. The median estimate represents a +183.95% increase from the last price of 8.10.
The current consensus among 5 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date May 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.